Phase I study of an oral formulation of irinotecan administered daily for 14 days every 3 weeks in patients with advanced solid tumours
Titel:
Phase I study of an oral formulation of irinotecan administered daily for 14 days every 3 weeks in patients with advanced solid tumours
Auteur:
Schoemaker, Nadja E. Kuppens, I. E. L. M. Huinink, Wim W. Ten Bokkel Lefebvre, Patricia Beijnen, Jos H. Assadourian, Sylvie Sanderink, Ger-Jan Schellens, Jan H. M.